These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16890814)

  • 1. HIV/AIDS harm reduction in Iran.
    Razzaghi E; Nassirimanesh B; Afshar P; Ohiri K; Claeson M; Power R
    Lancet; 2006 Aug; 368(9534):434-5. PubMed ID: 16890814
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of HIV in Iran.
    Najafi Z; Taj L; Dadras O; Ghadimi F; Moradmand B; SeyedAlinaghi S
    Curr HIV Res; 2020; 18(4):228-236. PubMed ID: 32503409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Russia's HIV rate continues to rise with reactionary policies.
    Colborne M
    CMAJ; 2016 Sep; 188(13):E299-E300. PubMed ID: 27527480
    [No Abstract]   [Full Text] [Related]  

  • 4. Reasons for drug policy reform: people who use drugs are denied evidence based treatment.
    Kazatchkine M
    BMJ; 2017 Jan; 356():i6613. PubMed ID: 28096122
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV in injecting drug users in Asian countries.
    Wodak A; Ali R; Farrell M
    BMJ; 2004 Sep; 329(7468):697-8. PubMed ID: 15388591
    [No Abstract]   [Full Text] [Related]  

  • 6. Saskatchewan won't declare HIV emergency.
    Vogel L
    CMAJ; 2016 Oct; 188(15):1071-1072. PubMed ID: 27672224
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies to Reduce HIV Transmission amongst Prisoners; Lessons Learned From Iran.
    Bagheri Lankarani K; Zarei N; Joulaei H
    J Res Health Sci; 2017 Jul; 17(3):e00385. PubMed ID: 28878114
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
    Greenberg M
    Dis Mon; 2019 May; 65(5):118. PubMed ID: 30718005
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Atrocity in the Philippines: How Rodrigo Duterte's War on Drug Users May Exacerbate the Burgeoning HIV Epidemic.
    Dombrowski JC; Dorabjee J; Strathdee SA
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):23-25. PubMed ID: 28797018
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Des Jarlais et al. (2017): Robust public health policies as a way forward in the HIV epidemic.
    Whitehead NE
    Addiction; 2017 Feb; 112(2):299-300. PubMed ID: 28078705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenge of Vanquishing HIV for the Next Generation-Facing the Future.
    Fitzpatrick MC; Gray GE; Galvani AP
    JAMA Pediatr; 2018 Jul; 172(7):609-610. PubMed ID: 29800028
    [No Abstract]   [Full Text] [Related]  

  • 12. The correlation between strength and range of motion of the neck muscles and opium smoking in Iran.
    Massah O; Arab AM; Farhoudian A; Noroozi M; Hashemirad F
    Front Psychiatry; 2023; 14():1200091. PubMed ID: 37324814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
    Rajabi A; Sharafi H; Alavian SM
    Harm Reduct J; 2021 Jan; 18(1):12. PubMed ID: 33482831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV in Iran: onset, responses, and future directions.
    SeyedAlinaghi S; Taj L; Mazaheri-Tehrani E; Ahsani-Nasab S; Abedinzadeh N; McFarland W; Mohraz M; Mirzazadeh A
    AIDS; 2021 Mar; 35(4):529-542. PubMed ID: 33252485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
    Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
    Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islam and cannabis: Legalisation and religious debate in Iran.
    Ghiabi M; Maarefvand M; Bahari H; Alavi Z
    Int J Drug Policy; 2018 Jun; 56():121-127. PubMed ID: 29635140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of Substance Use and Related Factors in Male Prisoners.
    Khalooei A; Mashayekhi-Dowlatabad M; Rajabalipour MR; Iranpour A
    Addict Health; 2016; 8(4):227-234. PubMed ID: 28819553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of gaming disorder in the diagnostic classifications and promotion of public health response.
    Shadloo B; Farnam R; Amin-Esmaeili M; Hamzehzadeh M; Rafiemanesh H; Jobehdar MM; Ghani K; Charkhgard N; Rahimi-Movaghar A
    J Behav Addict; 2017 Sep; 6(3):310-312. PubMed ID: 28816499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persian At-Risk Women and Barriers to Receiving HIV Services in Drug Treatment: First Report From Iran.
    Samiei M; Moradi A; Noori R; Aryanfard S; Rafiey H; Naranjiha H
    Int J High Risk Behav Addict; 2016 Jun; 5(2):e27488. PubMed ID: 27622170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.